Cargando…

TZD-Based Hybrid Molecules Act as Dual Anti-Mycobacterium tuberculosis and Anti-Toxoplasma gondii Agents

Two distinct intracellular pathogens, namely Mycobacterium tuberculosis (Mtb) and Toxoplasma gondii (Tg), cause major public health problems worldwide. In addition, serious and challenging health problems of co-infections of Tg with Mtb have been recorded, especially in developing countries. Due to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dzitko, Katarzyna, Kaproń, Barbara, Paneth, Agata, Bekier, Adrian, Plech, Tomasz, Paneth, Piotr, Trotsko, Nazar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916616/ https://www.ncbi.nlm.nih.gov/pubmed/36768392 http://dx.doi.org/10.3390/ijms24032069

Ejemplares similares

Inhibition of Toxoplasma gondii by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine
por: Węglińska, Lidia, et al.
Publicado: (2022)

Synthesis and In Vitro Anti-Toxoplasma gondii Activity of Novel Thiazolidin-4-one Derivatives
por: Trotsko, Nazar, et al.
Publicado: (2019)

4-Arylthiosemicarbazide derivatives as a new class of tyrosinase inhibitors and anti-Toxoplasma gondii agents
por: Bekier, Adrian, et al.
Publicado: (2021)

Systematic Identification of Thiosemicarbazides for Inhibition of Toxoplasma gondii Growth In Vitro
por: Paneth, Agata, et al.
Publicado: (2019)

1,3,4-Thiadiazoles Effectively Inhibit Proliferation of Toxoplasma gondii
por: Węglińska, Lidia, et al.
Publicado: (2021)

1,4-Disubstituted Thiosemicarbazide Derivatives are Potent Inhibitors of Toxoplasma gondii Proliferation
por: Dzitko, Katarzyna, et al.
Publicado: (2014)

Discovery of Potent and Selective Halogen-Substituted Imidazole-Thiosemicarbazides for Inhibition of Toxoplasma gondii Growth In Vitro via Structure-Based Design
por: Paneth, Agata, et al.
Publicado: (2019)

Thiazoles with cyclopropyl fragment as antifungal, anticonvulsant, and anti-Toxoplasma gondii agents: synthesis, toxicity evaluation, and molecular docking study
por: Łączkowski, Krzysztof Z., et al.
Publicado: (2018)

Synthesis, molecular docking, ctDNA interaction, DFT calculation and evaluation of antiproliferative and anti-Toxoplasma gondii activities of 2,4-diaminotriazine-thiazole derivatives
por: Łączkowski, Krzysztof Z., et al.
Publicado: (2018)

Imidazole-Thiosemicarbazide Derivatives as Potent Anti-Mycobacterium tuberculosis Compounds with Antibiofilm Activity
por: Bekier, Adrian, et al.
Publicado: (2021)

Synthesis and Antibacterial Activity of New Thiazolidine-2,4-dione-Based Chlorophenylthiosemicarbazone Hybrids
por: Trotsko, Nazar, et al.
Publicado: (2018)

4-Arylthiosemicarbazide Derivatives as Toxoplasmic Aromatic Amino Acid Hydroxylase Inhibitors and Anti-inflammatory Agents
por: Bekier, Adrian, et al.
Publicado: (2022)

Synergistic Effects of Thiosemicarbazides with Clinical Drugs against S. aureus
por: Chudzik-Rząd, Beata, et al.
Publicado: (2020)

Antibacterial Activity of Fluorobenzoylthiosemicarbazides and Their Cyclic Analogues with 1,2,4-Triazole Scaffold
por: Kosikowska, Urszula, et al.
Publicado: (2020)

Effect of Linker Elongation on the VGSC Affinity and Anticonvulsant Activity among 4-Alkyl-5-aryl-1,2,4-triazole-3-thione Derivatives
por: Paruch, Kinga, et al.
Publicado: (2023)

Synthesis and antibacterial activity of new (2,4-dioxothiazolidin-5-yl/ylidene)acetic acid derivatives with thiazolidine-2,4-dione, rhodanine and 2-thiohydantoin moieties
por: Trotsko, Nazar, et al.
Publicado: (2018)

Influence of Thiazolidine-2,4-Dione Derivatives with Azolidine or Thiosemicarbazone Moieties on Haemophilus spp. Planktonic or Biofilm-Forming Cells
por: Trotsko, Nazar, et al.
Publicado: (2019)

Synthesis and in vitro antiproliferative and antibacterial activity of new thiazolidine-2,4-dione derivatives
por: Trotsko, Nazar, et al.
Publicado: (2017)

Lipophilicity Studies on Thiosemicarbazide Derivatives
por: Paneth, Agata, et al.
Publicado: (2017)

Studies on the Anticonvulsant Activity and Influence on GABA-ergic Neurotransmission of 1,2,4-Triazole-3-thione-Based Compounds
por: Plech, Tomasz, et al.
Publicado: (2014)

Pharmacological and Structure-Activity Relationship Evaluation of 4-aryl-1-Diphenylacetyl(thio)semicarbazides
por: Wujec, Monika, et al.
Publicado: (2014)

Determination of the Primary Molecular Target of 1,2,4-Triazole-Ciprofloxacin Hybrids
por: Plech, Tomasz, et al.
Publicado: (2015)

Behavioral changes in mice caused by Toxoplasma gondii invasion of brain
por: Gatkowska, Justyna, et al.
Publicado: (2012)

Isotopic Consequences of Host–Guest Interactions; Noncovalent Chlorine Isotope Effects
por: Paneth, Agata, et al.
Publicado: (2021)

Thiosemicarbazide Derivatives Decrease the ATPase Activity of Staphylococcus aureus Topoisomerase IV, Inhibit Mycobacterial Growth, and Affect Replication in Mycobacterium smegmatis
por: Kowalczyk, Aleksandra, et al.
Publicado: (2021)

What do docking and QSAR tell us about the design of HIV-1 reverse transcriptase nonnucleoside inhibitors?
por: Paneth, Agata, et al.
Publicado: (2017)

Assessment of Nonnucleoside Inhibitors Binding to HIV-1 Reverse Transcriptase Using HYDE Scoring
por: Paneth, Agata, et al.
Publicado: (2019)

Docking and QSAR of Aminothioureas at the SARS-CoV-2 S-Protein–Human ACE2 Receptor Interface
por: Płonka, Wojciech, et al.
Publicado: (2020)

Unprecedently large (37)Cl/(35)Cl equilibrium isotopic fractionation on nano-confinement of chloride anion
por: Pokora, Mateusz, et al.
Publicado: (2022)

Non-Covalent Isotope Effects
por: Pokora, Mateusz, et al.
Publicado: (2023)

Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells
por: Dzitko, Katarzyna, et al.
Publicado: (2015)

A Search for Dual Action HIV-1 Reverse Transcriptase, Bacterial RNA Polymerase Inhibitors
por: Paneth, Agata, et al.
Publicado: (2017)

Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione - a novel anticonvulsant drug candidate
por: Kaproń, Barbara, et al.
Publicado: (2017)

The first study on the usefulness of recombinant tetravalent chimeric proteins containing fragments of SAG2, GRA1, ROP1 and AMA1 antigens in the detection of specific anti-Toxoplasma gondii antibodies in mouse and human sera
por: Ferra, Bartłomiej Tomasz, et al.
Publicado: (2019)

Toxoplasma gondii Recombinant antigen AMA1: Diagnostic Utility of Protein Fragments for the Detection of IgG and IgM Antibodies
por: Ferra, Bartłomiej, et al.
Publicado: (2020)

Treatments of Mycobacterium tuberculosis and Toxoplasma gondii with Selenium Nanoparticles
por: Ifijen, Ikhazuagbe H., et al.
Publicado: (2023)

Serologic Detection of Anti Toxoplasma gondii Infection in Diabetic Patients
por: Shirbazou, Shahnaz, et al.
Publicado: (2013)

Seroprevalence of anti-Toxoplasma gondii antibodies in Egyptian sheep and goats
por: Al-Kappany, Yara M., et al.
Publicado: (2018)

Promising Drug Targets and Compounds with Anti-Toxoplasma gondii Activity
por: da Silva, Marco, et al.
Publicado: (2021)

In vitro anti-Toxoplasma gondii efficacy of synthesised benzyltriazole derivatives
por: Guo, Huanping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7uqdrnhfglch79k561ooci3fgj